Structural neuroimaging in first-episode psychosis

  • Technology appraisal guidance
  • TA136
  • Published: 
Download guidance (PDF)

7 Sources of evidence considered by the Committee

The assessment report for this appraisal was prepared by the West Midlands Health Technology Assessment Group, University of Birmingham.

  • Albon E, Tsourapas A, Frew E et al. Structural neuroimaging in psychosis. Systematic review and economic evaluation, June 2007

The following organisations accepted the invitation to participate in this appraisal. They were invited to comment on the draft scope, the assessment report and the appraisal consultation document (ACD). Companies or sponsors, and professional or specialist, and patient or carer groups were also invited to make written submissions and have the opportunity to appeal against the Final Appraisal Determination.

Companies or sponsors:

  • GE Medical Systems

  • Phillips Medical Systems

Professional or specialist, and patient or carer groups:

  • Counsel and Care

  • Rethink

  • British Association for Psychopharmacology

  • British Neuropsychiatry Association

  • British Psychological Society

  • Royal College of General Practitioners

  • Royal College of Nursing

  • Royal College of Radiologists

Commentator organisations (without the right of appeal):

  • Department of Health, Social Services and Public Safety for Northern Ireland

  • EUCOMED

  • NHS Quality Improvement Scotland

  • Institute of Psychiatry

  • National Coordinating Centre for Health Technology Assessment

  • West Midlands HTA Collaboration

The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer or sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on structural neuroimaging by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Professor Philip McGuire, Professor of Psychiatry and Cognitive Neuroscience, Institute of Psychiatry – clinical specialist

  • Dr Sophia Frangou, Reader, Institute of Psychiatry – clinical specialist

ISBN: 978-1-4731-4211-4